Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane

By            

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1481-1490

Spandidos Publications

Access to resources Recommend Favorite

Exacerbation of diabetes related to exemestane treatment

By Senkus-konefka Elzbieta   Orłowska-kunikowska Elzbieta   Dziadziuszko Rafał   Jassem Jacek  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1167-1169

Informa Healthcare

Access to resources Recommend Favorite

Overview

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 18, Iss. 1, 2018-03 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Overview:

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 1, 2016-01 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite